Page last updated: 2024-10-22

aminoglutethimide and Neutropenia

aminoglutethimide has been researched along with Neutropenia in 2 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goetz, M1
Schiel, X1
Heussel, H1
Steinmetz, T1
Hiddemann, W1
Weiss, M1
Steinberg, JL1
Trudeau, ME1

Trials

1 trial available for aminoglutethimide and Neutropenia

ArticleYear
Elevation of soluble tumor necrosis factor receptor II in non-febrile patients with acute myeloid leukemia.
    European journal of medical research, 2002, Nov-25, Volume: 7, Issue:11

    Topics: Adult; Aged; Aminoglutethimide; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Danazo

2002

Other Studies

1 other study available for aminoglutethimide and Neutropenia

ArticleYear
Neutropenia induced by aminoglutethimide in breast cancer.
    Journal of the Royal Society of Medicine, 1993, Volume: 86, Issue:8

    Topics: Aged; Aminoglutethimide; Breast Neoplasms; Female; Humans; Neutropenia

1993